Bioperfectus
Taizhou, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A leading Chinese provider of integrated PCR systems and reagents for infectious disease and genetic diagnostics.
Infectious DiseaseGenetics & GenomicsDiagnostics
Technology Platform
Integrated platform featuring automated, high-throughput PCR systems and nucleic acid extraction workstations for molecular diagnostics.
Opportunities
Sustained global demand for decentralized and rapid molecular testing infrastructure post-pandemic.
Risk Factors
Market saturation for COVID-19 testing and potential slowdown in public health spending on diagnostics.
Competitive Landscape
A major domestic competitor in China's molecular diagnostics market, contending with other integrated platform providers.